Merck & Co., Inc. Portfolio Stock Holdings
According to the SEC 13F filed on August 7, 2026, Merck & Co., Inc. disclosed 13 stock positions valued at approximately $526.41M as of quarter-end June 30, 2026. The largest holdings include PERSONALIS INC, MODERNA INC, and KYMERA THERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 13
- Portfolio Value
- $526.41M
Holdings by Sector
Merck & Co., Inc. Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| PERSONALIS INC | PSNL | Healthcare | 35.75% | 14,044,943 | - | - | $188,202,236 |
| MODERNA INC | MRNA | Healthcare | 30.71% | 2,308,190 | - | - | $161,642,545 |
| KYMERA THERAPEUTICS INC | KYMR | Healthcare | 16.82% | 772,165 | - | - | $88,544,161 |
| AKTIS ONCOLOGY INC | AKTS | Other | 5.83% | 952,844 | - | - | $30,710,162 |
| EIKON THERAPEUTICS INC | EIKN | Other | 4.13% | 1,666,666 | - | - | $21,749,991 |
| ENTRADA THERAPEUTICS INC | TRDA | Healthcare | 2.43% | 1,739,768 | +1,739,768 | +100.00% | $12,804,692 |
| SUTRO BIOPHARMA INC | STRO | Other | 1.72% | 272,351 | - | - | $9,042,053 |
| ALECTOR INC | ALEC | Healthcare | 1.35% | 3,545,719 | - | - | $7,126,896 |
| EVAXION BIOTECH A/S | EVAX | Other | 0.71% | 1,214,126 | +1,214,126 | +100.00% | $3,763,791 |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 0.33% | 93,414 | - | - | $1,716,015 |
| XILIO THERAPEUTICS INC | XLO | Other | 0.19% | 105,982 | - | - | $1,015,308 |
| TUHURA BIOSCIENCES INC | HURA | Other | 0.01% | 19,445 | - | - | $45,501 |
| NEUPHORIA THERAPEUTICS INC | NEUP | Other | 0.01% | 10,027 | - | - | $43,818 |
Showing 13 of 13 holdings in the latest reporting period.